Events | 2020.10.20
Catalent to Discuss Data-Driven Development and Patient-Focused Dose Design Strategies at AAPS PharmSci 360
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that its experts will present at the upcoming American Association of Pharmaceutical Scientists (AAPS) PharmSci 360 event, which takes place virtually from Oct. 26 – Nov. 5, 2020.
(PRWeb October 20, 2020)
Read the full story at https://www.prweb.com/releases/catalent_to_discuss_data_driven_development_and_patient_focused_dose_design_strategies_at_aaps_pharmsci_360/prweb17484740.htm
For more information, please visit
https://www.prweb.com/releases/catalent_[...]pharmsci_360/prweb17484740.htm
